Innate’s lacutamab gains FDA breakthrough therapy designation
Innate Pharma has secured US Food and Drug Administration (FDA) breakthrough therapy designation for lacutamab to treat adults with relapsed…
Innate Pharma has secured US Food and Drug Administration (FDA) breakthrough therapy designation for lacutamab to treat adults with relapsed…
GSK has secured approval from the US Food and Drug Administration (FDA) for its new vaccine, Penmenvy, to protect against…
Moderna has reported revenue of $1bn for the fourth quarter (Q4) of 2024 - a sharp decline from the $2.8bn…
Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and cardiometabolic…
CTI Clinical Trial & Consulting Services (CTI) and Crown Bioscience have announced a strategic partnership aimed at bolstering consulting services…
Contract development and manufacturing organisation Touchlight has collaborated with the UK's University of Nottingham to supply good manufacturing practice (GMP)…
China's National Medical Products Administration (NMPA) has granted approval for Innovent Biologics’ Kristen rat sarcoma (KRAS) G12C inhibitor, Dupert (fulzerasib),…
The US Food and Drug Administration (FDA) has accepted the supplemental biologics licence application (sBLA) filed by Bristol Myers Squibb…
Accenture has invested in biotechnology company Earli to advance early cancer detection technologies. Facilitated through Accenture Ventures, the investment aims…
Biopharmaceutical company Liquidia has received tentative approval from the US Food and Drug Administration (FDA) for YUTREPIA (treprostinil) inhalation powder…